About
Profile
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
NRXP
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- NRx Pharmaceuticals GAAP EPS of -$0.61
- DSMB recommends NRx Pharma to continue trial evaluating its bipolar depression treatment
- NRx says FDA suggests broadening use of bipolar depression disorder drug in trial
- NRx Pharma gains on FDA comments regarding lead asset
- NRx Pharma gains as Phase 3 trial for bipolar candidate starts
- NRx Pharmaceuticals regains Nasdaq compliance
- NRx Pharmaceuticals GAAP EPS of -$0.14
- Relief, NRx reach settlement over COVID-19 therapy aviptadil
- NRx Pharma announces commercial production of drug targeted at suicidal depression
- Relief, NRx extend time to settle litigation over COVID-19 therapy aviptadil
- Relief, NRx agree to settle litigation over COVID-19 therapy aviptadil
- NRx Pharmaceuticals reports Q2 results
- Stephen Willard is the new CEO of NRx Pharmaceuticals
- NRx Pharma fails to win FDA clearance for COVID therapy
- NRx Pharma says class action suit against company dismissed
- NRx Pharmaceuticals names Seth Van Voorhees as CFO
- NRx Pharma says trial for COVID-19 therapy did not meet key goals
- NRx Pharmaceuticals GAAP EPS of -$0.21
- NRx Pharma begins phase II trial to test bipolar depression drug candidate
- NRx Pharmaceuticals seeks FDA breakthrough therapy tag for COVID-19 drug Zyesami
Earnings History
Date | EPS / Forecast | Revenue / Forecast | |
---|---|---|---|
November 15, 2021 | -0.4 / - | - / - | |
August 16, 2021 | -6.51 / - | - / - | |
May 21, 2021 | -0.33 / - | - / - | |
April 1, 2021 | -0.16 / - | - / - | |
November 16, 2020 | -0.05 / - | - / - | |
August 14, 2020 | -0.06 / - | - / - | |
May 15, 2020 | 0.1 / - | - / - |
Date | Price | Open | High | Low | Vol | Change | ER | |||
---|---|---|---|---|---|---|---|---|---|---|
May 16 | 1.36 | 1.40 |
1.47
|
1.32
|
452.69K | 3.03% | ||||
May 13 | 1.32 | 1.30 |
1.34
|
1.22
|
501.48K | 8.20% | ||||
May 12 | 1.22 | 1.24 |
1.35
|
1.16
|
761.15K | 4.27% | ||||
May 11 | 1.17 | 1.27 |
1.30
|
1.15
|
442.27K | -10.69% | ||||
May 10 | 1.31 | 1.41 |
1.42
|
1.28
|
330.51K | -2.96% | ||||
May 9 | 1.35 | 1.49 |
1.51
|
1.32
|
402.18K | -10.6% | ||||
May 6 | 1.51 | 1.70 |
1.70
|
1.49
|
347.04K | -10.12% | ||||
May 5 | 1.68 | 1.63 |
1.69
|
1.51
|
722.86K | 3.07% | ||||
May 4 | 1.63 | 1.64 |
1.68
|
1.56
|
405.42K | -1.81% | ||||
May 3 | 1.66 | 1.63 |
1.68
|
1.48
|
563.81K | 7.10% | ||||
May 2 | 1.55 | 1.53 |
1.64
|
1.49
|
553.46K | -0.64% | ||||
Apr 29 | 1.56 | 1.57 |
1.61
|
1.51
|
348.20K | 0.65% | ||||
Apr 28 | 1.55 | 1.70 |
1.70
|
1.49
|
585.58K | -7.74% | ||||
Apr 27 | 1.68 | 1.65 |
1.71
|
1.61
|
438.53K | -0.59% | ||||
Apr 26 | 1.69 | 1.74 |
1.81
|
1.65
|
268.47K | -7.14% | ||||
Apr 25 | 1.82 | 1.61 |
1.85
|
1.59
|
559.79K | 7.06% | ||||
Apr 22 | 1.70 | 1.80 |
1.81
|
1.62
|
611.76K | -8.11% | ||||
Apr 21 | 1.85 | 2.15 |
2.18
|
1.85
|
967.44K | -13.15% | ||||
Apr 20 | 2.13 | 2.17 |
2.20
|
2.12
|
358.68K | -3.18% | ||||
Apr 19 | 2.20 | 2.14 |
2.24
|
2.10
|
283.64K | 2.33% | ||||
Apr 18 | 2.15 | 2.36 |
2.36
|
2.15
|
250.76K | -11.16% |